Nanotoxicity: the growing need for in vivo study.

By H. Fischer, W. Chan. Current Opinion in Biotechnology, 2007

693 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/c2f9fa0f6ff7ecb3a7afb2c4d260dab4f8404733

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Materials Chemistry

Citations in the corpus

Interactions of nanomaterials and biological systems: implications to personalized nanomedicine (2012, background): “However, biodegradable materials may also cause toxic effects if the degraded components of the material are toxic [217].”
Biocompatibility of engineered nanoparticles for drug delivery. (2013, background): “inherent physicochemical properties such as surface charge, hydrophobicity, solubility, size, shape, and aggregation tendencies which can be engineered to trigger different biological responses [8,12].”
Toxicity assessment of nanomaterials: methods and challenges (2010, background): “Several of these methods and the challenges they face from nanoparticles have recently been discussed [19–23].”
Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? (2010, neutral): “Moreover, the majority of the scientific reports that investigate the cellular impact of nanomaterials are in vitro, with far less effort to understand the real situation in vivo (Fischer and Chan 2007).”
Effect of gold nanoparticle aggregation on cell uptake and toxicity. (2011, background): “It has been speculated that the unique properties of NPs could cause various toxic responses.(64,65) We incubated the three cell lines at multiple aggregate concen-”
Effects of nanomaterial physicochemical properties on in vivo toxicity (2009, neutral): “The majority of nanotoxicity studies have focused on health effects of exposure to ultrafine (unintentionally produced) particles by inhalation, contact through skin, or ingestion [1,6-9].”